Atlas Trials

Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System

Clinical trial NCT02690805 · COMPLETED

Trial details

NCT number
NCT02690805
Sponsor
University of California, Irvine
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2015-05-01
Primary completion
2019-01-25
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.